A Phase I Study of Nivolumab in Combination with Ipilimumab for the Treatment of Patients with High Risk or Refractory/Relapsed Acute Myeloid Leukemia Following Allogeneic Stem Cell Transplantation Gheath Alatrash , Cristina Knape , Laura Whited , Dawen Sui , Cara L Haymaker , Jason Yeh , Megan Marcotulli , Pariya Sukhumalchandra , Lisa St. John , Hsinyi Lu , Daniela E. Duenas , Ignacio Wistuba , Julia Mendoza Perez , Beatriz Sanchez Espiridion , Roland L. Bassett , Tapan M. Kadia , Courtney D. DiNardo , Farhad Ravandi , Jeremy Ramdial , Rohtesh S. Mehta , Amin M. Alousi , Betul Oran , Issa F. Khouri , Qaiser Bashir , Chitra Hosing , Muzaffar H. Qazilbash , Jin S. Im , Partow Kebriaei , Pavan Bachireddy , Jeffrey J. Molldrem , Jeffrey L. Jorgensen , Sa A. Wang , Wei WANG , Uday Popat , Elizabeth J. Shpall , Richard E. Champlin , Hagop M. Kantarjian , Naval Daver Blood（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
